T細胞表面糖タンパク質CD3イプシロン鎖の世界市場（～2026年）

• 英文タイトル：Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY10448
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、114ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料はT細胞表面糖タンパク質CD3イプシロン鎖のグローバル市場について調査・分析したレポートです。種類別（ND-007、フォラルマブ、コルテリズマブ、AVA-002、その他）市場規模、用途別（自己免疫疾患、B型肝炎、多発性硬化症、前立腺がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別T細胞表面糖タンパク質CD3イプシロン鎖の競争状況、市場シェア
・世界のT細胞表面糖タンパク質CD3イプシロン鎖市場：種類別市場規模 2015年-2020年（ND-007、フォラルマブ、コルテリズマブ、AVA-002、その他）
・世界のT細胞表面糖タンパク質CD3イプシロン鎖市場：種類別市場規模予測 2021年-2026年（ND-007、フォラルマブ、コルテリズマブ、AVA-002、その他）
・世界のT細胞表面糖タンパク質CD3イプシロン鎖市場：用途別市場規模 2015年-2020年（自己免疫疾患、B型肝炎、多発性硬化症、前立腺がん、その他）
・世界のT細胞表面糖タンパク質CD3イプシロン鎖市場：用途別市場規模予測 2021年-2026年（自己免疫疾患、B型肝炎、多発性硬化症、前立腺がん、その他）
・北米のT細胞表面糖タンパク質CD3イプシロン鎖市場分析：米国、カナダ
・ヨーロッパのT細胞表面糖タンパク質CD3イプシロン鎖市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのT細胞表面糖タンパク質CD3イプシロン鎖市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のT細胞表面糖タンパク質CD3イプシロン鎖市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのT細胞表面糖タンパク質CD3イプシロン鎖市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Amgen Inc、Celgene Corp、F. Hoffmann-La Roche Ltd、GlaxoSmithKline Plc、MacroGenics Inc、Meridigen Biotech Co Ltd、Numab Innovation AG、SYNIMMUNE GmbH、Tiziana Life Sciences Plc
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market
The global T Cell Surface Glycoprotein CD3 Epsilon Chain market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global T Cell Surface Glycoprotein CD3 Epsilon Chain Scope and Market Size
T Cell Surface Glycoprotein CD3 Epsilon Chain market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global T Cell Surface Glycoprotein CD3 Epsilon Chain market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the T Cell Surface Glycoprotein CD3 Epsilon Chain market is segmented into
ND-007
Foralumab
Coltelizumab
AVA-002
Others

Segment by Application, the T Cell Surface Glycoprotein CD3 Epsilon Chain market is segmented into
Autoimmune Disorders
Hepatitis B
Multiple Sclerosis
Prostate Cancer
Others

Regional and Country-level Analysis
The T Cell Surface Glycoprotein CD3 Epsilon Chain market is analysed and market size information is provided by regions (countries).
The key regions covered in the T Cell Surface Glycoprotein CD3 Epsilon Chain market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share Analysis
T Cell Surface Glycoprotein CD3 Epsilon Chain market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in T Cell Surface Glycoprotein CD3 Epsilon Chain business, the date to enter into the T Cell Surface Glycoprotein CD3 Epsilon Chain market, T Cell Surface Glycoprotein CD3 Epsilon Chain product introduction, recent developments, etc.

The major vendors covered:
Amgen Inc
Celgene Corp
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc
MacroGenics Inc
Meridigen Biotech Co Ltd
Numab Innovation AG
SYNIMMUNE GmbH
Tiziana Life Sciences Plc

レポート目次

1 Study Coverage
1.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Product Introduction
1.2 Market Segments
1.3 Key T Cell Surface Glycoprotein CD3 Epsilon Chain Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth Rate by Type
1.4.2 ND-007
1.4.3 Foralumab
1.4.4 Coltelizumab
1.4.5 AVA-002
1.4.6 Others
1.5 Market by Application
1.5.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth Rate by Application
1.5.2 Autoimmune Disorders
1.5.3 Hepatitis B
1.5.4 Multiple Sclerosis
1.5.5 Prostate Cancer
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, Estimates and Forecasts
2.1.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue 2015-2026
2.1.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales 2015-2026
2.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Competitor Landscape by Players
3.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Manufacturers
3.1.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Manufacturers (2015-2020)
3.1.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Manufacturers (2015-2020)
3.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Manufacturers
3.2.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Manufacturers (2015-2020)
3.2.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Share by Manufacturers (2015-2020)
3.2.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in 2019
3.2.5 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 T Cell Surface Glycoprotein CD3 Epsilon Chain Price by Manufacturers
3.4 T Cell Surface Glycoprotein CD3 Epsilon Chain Manufacturing Base Distribution, Product Types
3.4.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers T Cell Surface Glycoprotein CD3 Epsilon Chain Product Type
3.4.3 Date of International Manufacturers Enter into T Cell Surface Glycoprotein CD3 Epsilon Chain Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2015-2020)
4.1.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Type (2015-2020)
4.1.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2015-2020)
4.1.3 T Cell Surface Glycoprotein CD3 Epsilon Chain Average Selling Price (ASP) by Type (2015-2026)
4.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Forecast by Type (2021-2026)
4.2.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Forecast by Type (2021-2026)
4.2.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Forecast by Type (2021-2026)
4.2.3 T Cell Surface Glycoprotein CD3 Epsilon Chain Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2015-2020)
5.1.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Application (2015-2020)
5.1.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2015-2020)
5.1.3 T Cell Surface Glycoprotein CD3 Epsilon Chain Price by Application (2015-2020)
5.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Forecast by Application (2021-2026)
5.2.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Forecast by Application (2021-2026)
5.2.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Forecast by Application (2021-2026)
5.2.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Price Forecast by Application (2021-2026)

6 North America
6.1 North America T Cell Surface Glycoprotein CD3 Epsilon Chain by Country
6.1.1 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Country
6.1.2 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Facts & Figures by Type
6.3 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Facts & Figures by Application

7 Europe
7.1 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain by Country
7.1.1 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Country
7.1.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Facts & Figures by Type
7.3 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain by Region
8.1.1 Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Region
8.1.2 Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Facts & Figures by Type
8.3 Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Facts & Figures by Application

9 Latin America
9.1 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain by Country
9.1.1 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Country
9.1.2 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Facts & Figures by Type
9.3 Central & South America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain by Country
10.1.1 Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Country
10.1.2 Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Facts & Figures by Type
10.3 Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Facts & Figures by Application

11 Company Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Corporation Information
11.1.2 Amgen Inc Description and Business Overview
11.1.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Products Offered
11.1.5 Amgen Inc Related Developments
11.2 Celgene Corp
11.2.1 Celgene Corp Corporation Information
11.2.2 Celgene Corp Description and Business Overview
11.2.3 Celgene Corp Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Products Offered
11.2.5 Celgene Corp Related Developments
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Corporation Information
11.3.2 F. Hoffmann-La Roche Ltd Description and Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Products Offered
11.3.5 F. Hoffmann-La Roche Ltd Related Developments
11.4 GlaxoSmithKline Plc
11.4.1 GlaxoSmithKline Plc Corporation Information
11.4.2 GlaxoSmithKline Plc Description and Business Overview
11.4.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Products Offered
11.4.5 GlaxoSmithKline Plc Related Developments
11.5 MacroGenics Inc
11.5.1 MacroGenics Inc Corporation Information
11.5.2 MacroGenics Inc Description and Business Overview
11.5.3 MacroGenics Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Products Offered
11.5.5 MacroGenics Inc Related Developments
11.6 Meridigen Biotech Co Ltd
11.6.1 Meridigen Biotech Co Ltd Corporation Information
11.6.2 Meridigen Biotech Co Ltd Description and Business Overview
11.6.3 Meridigen Biotech Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Products Offered
11.6.5 Meridigen Biotech Co Ltd Related Developments
11.7 Numab Innovation AG
11.7.1 Numab Innovation AG Corporation Information
11.7.2 Numab Innovation AG Description and Business Overview
11.7.3 Numab Innovation AG Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Products Offered
11.7.5 Numab Innovation AG Related Developments
11.8 SYNIMMUNE GmbH
11.8.1 SYNIMMUNE GmbH Corporation Information
11.8.2 SYNIMMUNE GmbH Description and Business Overview
11.8.3 SYNIMMUNE GmbH Sales, Revenue and Gross Margin (2015-2020)
11.8.4 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Products Offered
11.8.5 SYNIMMUNE GmbH Related Developments
11.9 Tiziana Life Sciences Plc
11.9.1 Tiziana Life Sciences Plc Corporation Information
11.9.2 Tiziana Life Sciences Plc Description and Business Overview
11.9.3 Tiziana Life Sciences Plc Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Products Offered
11.9.5 Tiziana Life Sciences Plc Related Developments
11.1 Amgen Inc
11.1.1 Amgen Inc Corporation Information
11.1.2 Amgen Inc Description and Business Overview
11.1.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Products Offered
11.1.5 Amgen Inc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Estimates and Projections by Region
12.1.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Forecast by Regions 2021-2026
12.1.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Forecast by Regions 2021-2026
12.2 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Forecast (2021-2026)
12.2.1 North America: T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Forecast (2021-2026)
12.2.2 North America: T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Forecast (2021-2026)
12.2.3 North America: T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Forecast by Country (2021-2026)
12.3 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Forecast (2021-2026)
12.3.1 Europe: T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Forecast (2021-2026)
12.3.2 Europe: T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Forecast (2021-2026)
12.3.3 Europe: T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Forecast (2021-2026)
12.4.2 Asia Pacific: T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Forecast by Region (2021-2026)
12.5 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Forecast (2021-2026)
12.5.1 Latin America: T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Forecast (2021-2026)
12.5.2 Latin America: T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Forecast (2021-2026)
12.5.3 Latin America: T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key T Cell Surface Glycoprotein CD3 Epsilon Chain Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Segments
Table 2. Ranking of Global Top T Cell Surface Glycoprotein CD3 Epsilon Chain Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of ND-007
Table 5. Major Manufacturers of Foralumab
Table 6. Major Manufacturers of Coltelizumab
Table 7. Major Manufacturers of AVA-002
Table 8. Major Manufacturers of Others
Table 9. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Regions 2015-2020 (K Pcs)
Table 12. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Regions (2015-2020)
Table 13. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Share by Manufacturers (2015-2020)
Table 16. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global T Cell Surface Glycoprotein CD3 Epsilon Chain by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain as of 2019)
Table 18. T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers T Cell Surface Glycoprotein CD3 Epsilon Chain Price (2015-2020) (USD/Pcs)
Table 21. T Cell Surface Glycoprotein CD3 Epsilon Chain Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers T Cell Surface Glycoprotein CD3 Epsilon Chain Product Type
Table 23. Date of International Manufacturers Enter into T Cell Surface Glycoprotein CD3 Epsilon Chain Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Type (2015-2020) (K Pcs)
Table 26. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Share by Type (2015-2020)
Table 27. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2015-2020) (US$ Million)
Table 28. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Share by Type (2015-2020)
Table 29. T Cell Surface Glycoprotein CD3 Epsilon Chain Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Application (2015-2020) (K Pcs)
Table 31. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Share by Application (2015-2020)
Table 32. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Country (2015-2020) (K Pcs)
Table 33. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Country (2015-2020)
Table 34. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country (2015-2020) (US$ Million)
Table 35. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Country (2015-2020)
Table 36. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Type (2015-2020) (K Pcs)
Table 37. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Type (2015-2020)
Table 38. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Application (2015-2020) (K Pcs)
Table 39. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Application (2015-2020)
Table 40. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Country (2015-2020) (K Pcs)
Table 41. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Country (2015-2020)
Table 42. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Country (2015-2020)
Table 44. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Type (2015-2020) (K Pcs)
Table 45. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Type (2015-2020)
Table 46. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Application (2015-2020) (K Pcs)
Table 47. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Application (2015-2020)
Table 56. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Country (2015-2020)
Table 60. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Type (2015-2020)
Table 62. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Application (2015-2020)
Table 72. Amgen Inc Corporation Information
Table 73. Amgen Inc Description and Major Businesses
Table 74. Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Amgen Inc Product
Table 76. Amgen Inc Recent Development
Table 77. Celgene Corp Corporation Information
Table 78. Celgene Corp Description and Major Businesses
Table 79. Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Celgene Corp Product
Table 81. Celgene Corp Recent Development
Table 82. F. Hoffmann-La Roche Ltd Corporation Information
Table 83. F. Hoffmann-La Roche Ltd Description and Major Businesses
Table 84. F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. F. Hoffmann-La Roche Ltd Product
Table 86. F. Hoffmann-La Roche Ltd Recent Development
Table 87. GlaxoSmithKline Plc Corporation Information
Table 88. GlaxoSmithKline Plc Description and Major Businesses
Table 89. GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. GlaxoSmithKline Plc Product
Table 91. GlaxoSmithKline Plc Recent Development
Table 92. MacroGenics Inc Corporation Information
Table 93. MacroGenics Inc Description and Major Businesses
Table 94. MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. MacroGenics Inc Product
Table 96. MacroGenics Inc Recent Development
Table 97. Meridigen Biotech Co Ltd Corporation Information
Table 98. Meridigen Biotech Co Ltd Description and Major Businesses
Table 99. Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Meridigen Biotech Co Ltd Product
Table 101. Meridigen Biotech Co Ltd Recent Development
Table 102. Numab Innovation AG Corporation Information
Table 103. Numab Innovation AG Description and Major Businesses
Table 104. Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Numab Innovation AG Product
Table 106. Numab Innovation AG Recent Development
Table 107. SYNIMMUNE GmbH Corporation Information
Table 108. SYNIMMUNE GmbH Description and Major Businesses
Table 109. SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. SYNIMMUNE GmbH Product
Table 111. SYNIMMUNE GmbH Recent Development
Table 112. Tiziana Life Sciences Plc Corporation Information
Table 113. Tiziana Life Sciences Plc Description and Major Businesses
Table 114. Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Tiziana Life Sciences Plc Product
Table 116. Tiziana Life Sciences Plc Recent Development
Table 117. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Forecast by Regions (2021-2026) (K Pcs)
Table 118. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share Forecast by Regions (2021-2026)
Table 119. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 120. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share Forecast by Regions (2021-2026)
Table 121. North America: T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Forecast by Country (2021-2026) (K Pcs)
Table 122. North America: T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Europe: T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Forecast by Country (2021-2026) (K Pcs)
Table 124. Europe: T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Asia Pacific: T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Forecast by Region (2021-2026) (K Pcs)
Table 126. Asia Pacific: T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Forecast by Region (2021-2026) (US$ Million)
Table 127. Latin America: T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Forecast by Country (2021-2026) (K Pcs)
Table 128. Latin America: T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Middle East and Africa: T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Forecast by Country (2021-2026) (K Pcs)
Table 130. Middle East and Africa: T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 132. Key Challenges
Table 133. Market Risks
Table 134. Main Points Interviewed from Key T Cell Surface Glycoprotein CD3 Epsilon Chain Players
Table 135. T Cell Surface Glycoprotein CD3 Epsilon Chain Customers List
Table 136. T Cell Surface Glycoprotein CD3 Epsilon Chain Distributors List
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. T Cell Surface Glycoprotein CD3 Epsilon Chain Product Picture
Figure 2. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Type in 2020 & 2026
Figure 3. ND-007 Product Picture
Figure 4. Foralumab Product Picture
Figure 5. Coltelizumab Product Picture
Figure 6. AVA-002 Product Picture
Figure 7. Others Product Picture
Figure 8. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Application in 2020 & 2026
Figure 9. Autoimmune Disorders
Figure 10. Hepatitis B
Figure 11. Multiple Sclerosis
Figure 12. Prostate Cancer
Figure 13. Others
Figure 14. T Cell Surface Glycoprotein CD3 Epsilon Chain Report Years Considered
Figure 15. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2015-2026 (US$ Million)
Figure 16. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales 2015-2026 (K Pcs)
Figure 17. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Region (2015-2020)
Figure 19. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Region in 2019
Figure 20. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Region (2015-2020)
Figure 21. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Region in 2019
Figure 22. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in 2019
Figure 24. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Type (2015-2020)
Figure 26. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Type in 2019
Figure 27. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2015-2020)
Figure 28. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type in 2019
Figure 29. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Price Range (2015-2020)
Figure 30. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Application (2015-2020)
Figure 31. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Application in 2019
Figure 32. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Application (2015-2020)
Figure 33. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Application in 2019
Figure 34. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Country in 2019
Figure 37. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Country in 2019
Figure 38. U.S. T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Type in 2019
Figure 43. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Application in 2019
Figure 44. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Country in 2019
Figure 47. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Country in 2019
Figure 48. Germany T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Type in 2019
Figure 59. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Application in 2019
Figure 60. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Region in 2019
Figure 63. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Region in 2019
Figure 64. China T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Type in 2019
Figure 87. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Application in 2019
Figure 88. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Country in 2019
Figure 91. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Country in 2019
Figure 92. Mexico T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Type in 2019
Figure 99. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Application in 2019
Figure 100. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Country in 2019
Figure 103. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Country in 2019
Figure 104. Turkey T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Type in 2019
Figure 111. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Application in 2019
Figure 112. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed

以下、関連資料のご紹介

T細胞特異的表面糖タンパク質CD28の世界市場（～2026年）

Global T Cell Specific Surface Glycoprotein CD28 Market Insights and Forecast to 2026
MRC2-11QY10447 2020年11月25日 111Pages
当調査資料はT細胞特異的表面糖タンパク質CD28のグローバル市場について調査・分析したレポートです。種類別（FPT-155、FR-104、ルリズマブペゴル、その他）市場規模、用途別（尋常性乾癬、固形腫瘍、急性腎不全（ARF）、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス...

T細胞表面糖タンパク質CD4の世界市場（～2026年）

Global T Cell Surface Glycoprotein CD4 Market Insights and Forecast to 2026
MRC2-11QY10449 2020年11月25日 111Pages
当調査資料はT細胞表面糖タンパク質CD4のグローバル市場について調査・分析したレポートです。種類別（酢酸フォリゲリモド、HIVワクチン2、イバリズマブ、その他）市場規模、用途別（HIV、エイズ、GVHD、SARS、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...

細胞表面マーカー検出の世界市場（～2026年）

Global Cell Surface Marker Detection Market Size, Status and Forecast 2020-2026
MRC2-11QY11310 2020年11月25日 95Pages
当調査資料は細胞表面マーカー検出のグローバル市場について調査・分析したレポートです。種類別（フローサイトメトリー、血液分析装置、試薬・キット）市場規模、用途別（病気診断、病気特定、創薬研究、細胞学的学術研究）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシ...

プロテインキナーゼCイプシロンタイプの世界市場（～2026年）

Global Protein Kinase C Epsilon Type Market Insights and Forecast to 2026
MRC2-11QY14457 2020年11月30日 118Pages
当調査資料はプロテインキナーゼCイプシロンタイプのグローバル市場について調査・分析したレポートです。種類別（ブリオスタチン-1、DHACP-6、VMD-1201、その他）市場規模、用途別（アルコール依存症、頭・頸部がん、虚血性脳卒中、神経学、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、...

呼吸器合胞体ウイルス付着糖タンパク質の世界市場（～2026年）

Global Respiratory Syncytial Virus Attachment Glycoprotein Market Insights and Forecast to 2026
MRC2-11QY09085 2020年11月25日 115Pages
当調査資料は呼吸器合胞体ウイルス付着糖タンパク質のグローバル市場について調査・分析したレポートです。種類別（VIS-RSV、TRL-3D3、AX-14、MVA-RSV、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イ...

細胞培養タンパク質表面コーティングの世界市場（～2026年）

Global Cell Culture Protein Surface Coating Market Insights and Forecast to 2026
MRC2-11QY00041 2020年11月20日 112Pages
当調査資料は細胞培養タンパク質表面コーティングのグローバル市場について調査・分析したレポートです。種類別（動物由来タンパク質、ヒト由来タンパク質、合成タンパク質、植物由来タンパク質）市場規模、用途別（モノクローナル抗体、タンパク質治療薬、人工多能性幹細胞研究、クライオバンキング、細胞ベースアッセイ開...

心臓イメージングの世界市場（～2026年）

Global Cardiac Imaging Market Size, Status and Forecast 2020-2026
MRC2-11QY11261 2020年11月25日 96Pages
当調査資料は心臓イメージングのグローバル市場について調査・分析したレポートです。種類別（冠動脈カテーテル検査、心エコー検査、血管内超音波、ポジトロンエミッショントモグラフィー、コンピューター断層撮影、磁気共鳴血管造影）市場規模、用途別（病院、心臓センター、外来手術センター）市場規模、地域別（北米、米...

白血球表面抗原CD47の世界市場（～2026年）

Global Leukocyte Surface Antigen CD47 Market Insights and Forecast to 2026
MRC2-11QY07177 2020年11月20日 117Pages
当調査資料は白血球表面抗原CD47のグローバル市場について調査・分析したレポートです。種類別（B-6H12、ALX-148、CC-90002、PSTx-23、その他）市場規模、用途別（リンパ腫、卵巣癌、虚血再灌流障害、腎臓移植拒絶反応、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ...

表面タンパク質gp120の世界市場（～2026年）

Global Surface Protein gp120 Market Insights and Forecast to 2026
MRC2-11QY10339 2020年11月25日 119Pages
当調査資料は表面タンパク質gp120のグローバル市場について調査・分析したレポートです。種類別（DS-003、BMD-104、HNG-156、M-48U1、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、...

露天掘りの世界市場（～2026年）

Global Surface Mining Market Size, Status and Forecast 2020-2026
MRC2-11QY04764 2020年11月20日 90Pages
当調査資料は露天掘りのグローバル市場について調査・分析したレポートです。種類別（露天掘り、テラスマイニング、露天掘りマイニング）市場規模、用途別（鉄鉱石、石炭、銅鉱石、ダイヤモンド、クロム、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...

T細胞特異的表面糖タンパク質CD28の世界市場（～2026年） Market Analysis and Insights: Global T Cell Specific Surface Glycoprotein CD28 Market The global T Cell Specific Surface Glycoprotein CD28 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global T Cell Specific Surface Glycopr…
T細胞表面糖タンパク質CD4の世界市場（～2026年） Market Analysis and Insights: Global T Cell Surface Glycoprotein CD4 Market The global T Cell Surface Glycoprotein CD4 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global T Cell Surface Glycoprotein CD4 Scope and Market Si…
細胞表面マーカー検出の世界市場（～2026年） Cell surface markers are also known as cell surface antigen serves as monograms to help identify and classify cells. There is an increase in demand for the cell surface marker detection market owing to the advancements in high-throughput tools and techniques used for cytological analysis. Market Ana…
細胞培養タンパク質表面コーティングの世界市場（～2026年） Cell culture is a complex procedure in which cells are grown under controlled physical conditions outside the natural environment. These cells are used to develop model systems for research, study of cellular structure and functions, stem cell research, drug discovery and genetic engineering. Growin…
プロテインキナーゼCイプシロンタイプの世界市場（～2026年） Market Analysis and Insights: Global Protein Kinase C Epsilon Type Market The global Protein Kinase C Epsilon Type market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Protein Kinase C Epsilon Type Scope and Market Size Pro…